Aliskiren Hemifumarate 25 mg | ≥98% LKT Laboratories, Inc. Renin inhibitor. More Information Supplier Page × Aliskiren Hemifumarate
Altrenogest 1 g | ≥98% LKT Laboratories, Inc. Synthetic progestogen; PR agonist. More Information Supplier Page × Altrenogest
Altrenogest 250 mg | ≥98% LKT Laboratories, Inc. Synthetic progestogen; PR agonist. More Information Supplier Page × Altrenogest
Altrenogest 100 mg | ≥98% LKT Laboratories, Inc. Synthetic progestogen; PR agonist. More Information Supplier Page × Altrenogest
Neratinib 100 mg | ≥98% LKT Laboratories, Inc. EGFR inhibitor. More Information Supplier Page × Neratinib
Neratinib 25 mg | ≥98% LKT Laboratories, Inc. EGFR inhibitor. More Information Supplier Page × Neratinib
Crizotinib 25 mg | ≥98% LKT Laboratories, Inc. ALK, ROS1, c-MET inhibitor. More Information Supplier Page × Crizotinib
Crizotinib 10 mg | ≥98% LKT Laboratories, Inc. ALK, ROS1, c-MET inhibitor. More Information Supplier Page × Crizotinib
Crizotinib 50 mg | ≥98% LKT Laboratories, Inc. ALK, ROS1, c-MET inhibitor. More Information Supplier Page × Crizotinib
Lenalidomide 250 mg | ≥98% LKT Laboratories, Inc. Thalidomide derivative; cereblon and TNF-α inhibitor. More Information Supplier Page × Lenalidomide
